ocz103-os
Small moleculeexperimental
Clinical trial activity
2 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01378143)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ocz103-os
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01844791 | Phase 2 | Sep 1, 2012 | Verlyx Pharma Inc, Wojewodzki Szpital |
| NCT01378143 | Phase 2 | Mar 1, 2011 | CSSS Alphonse-Desjardins, CSSS Champlain - Charles-Lemoyne Hospital, McGill University, Queen's University, Belfast, University of Lyon, Verlyx Pharma Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Verlyx Pharma Inc | For profit | 2 | 2 | 1 | 2011 |
| CSSS Alphonse-Desjardins | Academic/Hospital | 1 | 0 | 1 | 2011 |
| CSSS Champlain - Charles-Lemoyne Hospital | Academic/Hospital | 1 | 0 | 1 | 2011 |
| McGill University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Queen's University, Belfast | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Lyon | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Wojewodzki Szpital | Academic/Hospital | 1 | 0 | 1 | 2012 |
7 organizations
Page 1 / 1